{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:05:07Z","timestamp":1769555107998,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.oret.2024.10.026","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:08:11Z","timestamp":1731049691000},"page":"460-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations between Androgen Exposure, Polycystic Ovary Syndrome, and Transmasculine Individuals with Central Serous Chorioretinopathy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4352-0224","authenticated-orcid":false,"given":"Jonathan D.","family":"Shirian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-669X","authenticated-orcid":false,"given":"Jacqueline K.","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-3592","authenticated-orcid":false,"given":"Nikhil","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-5118","authenticated-orcid":false,"given":"Danny A.","family":"Mammo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.10.026_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00417-019-04486-w","article-title":"Corticosteroids usage and central serous chorioretinopathy: a meta-analysis","volume":"258","author":"Ge","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib2","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.10.026_bib3","first-page":"296","article-title":"Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a meta-analysis","volume":"11","author":"Liang","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib4","first-page":"22","article-title":"Central serous chorioretinopathy secondary to intramuscular testosterone therapy","volume":"2023","author":"Lockhart","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.oret.2024.10.026_bib5","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/IAE.0000000000000198","article-title":"Central serous chorioretinopathy in patients receiving exogenous testosterone therapy","volume":"34","author":"Nudleman","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2024.10.026_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.eye.6701905","article-title":"Central serous chorioretinopathy associated with testosterone therapy","volume":"20","author":"Ahad","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2024.10.026_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjo.2006.098277","article-title":"The potential role of testosterone in central serous chorioretinopathy","volume":"91","author":"Grieshaber","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ICB.0000000000000298","article-title":"Central serous chorioretinopathy in postmenopausal women receiving exogenous testosterone","volume":"11","author":"Conway","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2024.10.026_bib9","author":"Kornblau"},{"key":"10.1016\/j.oret.2024.10.026_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000526052","article-title":"Sex hormones in males and females with active central serous chorioretinopathy","volume":"245","author":"Brinks","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2024.10.026_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00417-012-2075-8","article-title":"Serum cortisol and testosterone levels in chronic central serous chorioretinopathy","volume":"251","author":"Tufan","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0301-4738.57143","article-title":"Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy","volume":"57","author":"Zakir","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40123-023-00658-4","article-title":"Risk of central serous chorioretinopathy in male androgen abusers","volume":"12","author":"Subhi","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.oret.2024.10.026_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.oret.2024.10.026_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.oret.2024.10.026_bib16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.oret.2024.10.026_bib17","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.oret.2024.10.026_bib18","first-page":"261","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.oret.2024.10.026_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3928\/23258160-20150610-16","article-title":"Polycystic ovary syndrome and central serous chorioretinopathy","volume":"46","author":"Witmer","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2024.10.026_bib20","article-title":"Central serous chorioretinopathy in course of polycystic ovary syndrome - literature review","volume":"9","author":"Ochwa\u0142-Brzezinka","year":"2022","journal-title":"JOJ Ophthalmol"},{"key":"10.1016\/j.oret.2024.10.026_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MLR.0000000000001362","article-title":"Beyond gender identity disorder diagnoses codes: an examination of additional methods to identify transgender individuals in administrative databases","volume":"58","author":"Jasuja","year":"2020","journal-title":"Med Care"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302400527X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302400527X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:30:09Z","timestamp":1745998209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302400527X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S246865302400527X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.10.026","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between Androgen Exposure, Polycystic Ovary Syndrome, and Transmasculine Individuals with Central Serous Chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}